April 2019

Journal Articles

Adams, A., Kevin, R. C., Macdonald, C., Glass, M., Boyd, R., Connor, M., McGregor, I. S., Havel, C. M., Bright, S. J.,Ventura, M.,Gil, C.,Barratt, M. J., & Gerona, R. R. (2019). Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold hopping analogue of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA. Drug Testing and Analysis, 11(2), 279-291.doi: 10.1002/dta.2491

Alammehrjerdi, Z., Briggs, N. E., Biglarian, A., Mokri, A., & Dolan, K. (2019). A randomized controlled trial of brief cognitive behavioral therapy for regular methamphetamine use in methadone treatment. Journal of Psychoactive Drugs, Advance online publication. doi:10.1080/02791072.2019.1578445

Berry, J., Jacomb, I., Lunn, J., Sedwell, A., Shakeshaft, A., Kelly, P. J., Sarrami, P., James, M., Russell, S., Nardo, T., Barker, D., & Holmes, J. (2019). A stepped wedge cluster randomised controlled trial of a cognitive remediation intervention in alcohol and other drug (AOD) residential treatment services. BMC Psychiatry, 19(1). doi:10.1186/s12888-019-2044-4

Chan, G., Leung, J., Gartner, C., Yong, H-H., Borland, R., & Hall, W. (2019). Correlates of electronic cigarette use in the general population and among smokers in Australia – Findings from a nationally representative survey. Addictive Behaviors, 95, 6-9. doi:10.1016/j.addbeh.2019.02.012

Chapman, J., Naweed, A., Wilson, C., & Dorrian. J. (2019). Sleep for heart health: Investigating the relationship between work day sleep, days off sleep, and cardiovascular risk in Australian train drivers. Industrial Health. DOI:10.2486/indhealth.2018-0194

Clare, P. J., Dobbins, T. A., & Mattick, R. P. (2019). Causal models adjusting for time-varying confounding - a systematic review of the literature. International Journal of Epidemiology, 48(1), 254-265. doi: 10.1093/ije/dy218

Darke, S., Kaye, S., Duflou, J., & Lappin, J. (2019). Completed suicide among methamphetamine users: A national study. Suicide and Life-Threatening Behavior, 49(1), 328-337. doi: 10.1111/sltb.12442

Day, C. A., Coupland, H., Moensted, M., & Burns, L. (2018). The need for more research and considered debate regarding women-only treatment services: A comment on Neale et al (2018). Addiction, 113(9), 1750-1752. doi:10.1111/add.14364

Degenhardt, L., Bharat, C., Bruno, R., Glantz, M. D., Sampson, N. A. … Kessler, R. C. & on behalf of the WHO World Mental Health Survey Collaborators. (2019). Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys. Addiction, 114(3), 534-552. doi: 10.1111/add.14482

Farrugia, A.C., Fraser, S., Dwyer, R., Fomiatti, R., Neale, J., Dietze, P. and Strang, J. (2019). Take-home naloxone and the politics of care. Sociology of health and illness, 41, (2), pp. 427-443. DOI: 10.1111/1467-9566.12848
Link: https://doi.org/10.1111/1467-9566.12848

Farrugia, A.C., Neale, J., Dwyer, R., Fomiatti, R., Fraser, S., Strang, J. and Dietze, P. (2019). Conflict and communication: Managing the multiple affordances of take-home naloxone administration events in Australia. Addiction Research & Theory. DOI: 10.1080/16066359.2019.1571193.
Link: http://dx.doi.org/10.1080/16066359.2019.1571193

Fernández-Calderón, F., Díaz-Batanero, C., Barratt, M. J., & Palamar, J. J. (2019). Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs. Drug and Alcohol Review, 38(1), 57-67. doi:10.1111/dar.12868

Gisev, N., Nielsen, S., Campbell, G., Santo, T., Mant, A., Bruno, R., Cohen, M., Hall, W. D., Larance, B., Lintzeris, N., Farrell, M., & Degenhardt, L. (2019). Antidepressant use among people prescribed opioids for chronic noncancer pain. Pain Medicine, Advance online publication, 1-9. doi:10.1093/pm/pnz009

Gisev, N., Pearson, S.-A., Larance, B., Larney, S., Blanch, B., & Degenhardt, L. (2019). A population-based study of transdermal fentanyl initiation in Australian clinical practice. European Journal of Clinical Pharmacology, 75(3), 401-408. doi:10.1007/s00228-018-2588-0

Jacka, B., Kemp, R., Degenhardt, L., Peacock, A., Clare, P., Bruno, R., Dev, A., Sotade, O., & Larance, B.  (2019). Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015. Drug Alcohol Review, Advance online publication. doi:10.1111/dar.12908

Jacobs, N. I., Montebello, M., Monds, L. A., & Lintzeris, N. (2019). Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids. Australasian Psychiatry, 27(1), 80-85. doi:10.1177/1039856218803675

Kwon, J. A., Iversen, J., Law, M., Dolan, K., Wand, H., & Maher, L. (2019). Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016. Drug and Alcohol Dependence, 197, 108-114. doi:10.1016/j.drugalcdep.2018.11.033

Lalic, S., Ilomäki , J., Bell, J. S., Korhonen, M. J., & Gisev, N. (2019). Prevalence and incidence of prescription opioid analgesic use in Australia. British Journal of Clinical Pharmacology, 85(1), 202-215. doi:10.1111/bcp.13792

Larney, S., & Hall, W. (2019). A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA. The Lancet Public Health, 4(2), e77-e78. doi:10.1016/S2468-2667(19)30001-5

Liu, Q., Hu, L., Smith, J. L., & Mewton, L. R. (2019). Can inhibitory training produce reductions in drinking? Evaluating the influence of the control condition. Journal of Studies on Alcohol and Drugs, 80(1), 96-101. doi:10.15288/jsad.2019.80.96

Moore, D., Hart, A.C., Fraser, S. and Seear, K. (2019). Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance and image-enhancing drugs among men. Health. DOI: 10.1177/1363459319838595.
Link: http://dx.doi.org/10.1177/1363459319838595

Naghavi, M, on behalf of the Global Burden of Disease Self-Harm Collaborators, Degenhardt, L. (2019). Global, regional, and national burden of suicide mortality 1990 to 2016: a systematic analysis for the Global Burden of Disease Study 2016. BMJ, Advance online publication. doi:10.1136/bmj.194

Najman, J.M., Plotnikova, M., Horwood, J., Silins, E., Fergusson, D.M., Patton, G., Olsson, C.A., Hutchinson, D., Degenhardt, L., Tait, R.J., Youssef, G., Borschmann, R., Coffey, C., Toumbourou, J. and Mattick, R. (2019). Does adolescent heavier alcohol use predict young adult aggression and delinquency? Parallel analyses from four Australasian cohort studies. Aggressive Behavior. DOI: 10.1002/ab.21828.
Link: https://doi.org/10.1002/ab.21828

Palamar, J. J., & Barratt, M. J. (2019). Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in anelectronic dance music scene in New York City. Drug and Alcohol Review, 37(1), 42-49. doi: 10.1111/dar.12882

Peacock, A., Larance, B., Bruno, R., Pearson, S. A., Buckley, N. A., Farrell, M., & Degenhardt, L. (2019). Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations. Addiction, 114 (3) 404-405. doi: 10.1111/add.14556

Peacock, A., Larance, B., Bruno, R., Pearson, S.-A., Buckley, N. A., Farrell, M., & Degenhardt, L. (2019). Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting. Addiction, 114(3), 389-399. doi:10.1111/add.14380

Rapsey, C. M., Wells, J. E., Bharat, C., Glantz, M., Kessler, R. C., & Scott, K. M. (2019). Transitions through stages of alcohol use, use disorder and remission: Findings from Te Rau Hinengaro, the New Zealand Mental Health Survey. Alcohol and Alcoholism, 54(1), 87-96. doi:10.1093/alcalc/agy069

Ritter, A., & van de Ven, K. (2019). Is health or social welfare the right question? Response to commentaries. Drug and Alcohol Review, Advance online publication. doi:doi:10.1111/dar.12900

Ritter, A., Chalmers, J., & Gomez, M. (2019). Measuring unmet demand for alcohol and other drug treatment: The application of an Australian population-based planning model. Journal of Studies on Alcohol and Drugs, Supplement, (S.18), 42-50. doi:10.15288/jsads.2019.s18.42

Ritter, A., Mellor, R., Chalmers, J., Sunderland, M., & Lancaster, K. (2019). Key considerations in planning for substance use treatment: estimating treatment need and demand. Journal of Studies on Alcohol and Drugs, Supplement, (S.18), 22-30. doi:10.15288/jsads.2019.s18.22

Rowe, R., Ansara, G., Jaworski, A., Higgs, P., & Clare, P. J. (2018). What is the alcohol, tobacco, and other drug prevalence among culturally and linguistically diverse groups in hte Australian population? A national study of prevalence, harms, and attitudes. Journal of Ethnicity in Substance Abuse, Advance online publication, 1-18. doi:10.1080/15332640.2018.1484310

Schaffer, A. L., Karanges, E. A., Buckley, N. A., Wilson, A., Degenhardt, L., & Larance, B. (2019). Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study. Pharmacoepidemiology and Drug Safety, 28(1), 97-105. doi: 10.1002/pds.4683

Sharmin, S., Kypri, K., Wadolowski, M., Bruno, R., Khanam, M., Aiken, A., Hutchinson, D., Najman, J.M., Slade, T., McBride, N., Attia, J., Palazzi, K., Oldmeadow, C. and Mattick, R. (2019). Parental hazardous drinking and their children's alcohol use in early and mid-adolescence: Prospective cohort study. European Journal of Public Health, ckz029. DOI: 10.1093/eurpub/ckz029.
Link: https://doi.org/10.1093/eurpub/ckz029

Shatte, A. B. R., Hutchinson, D. M., & Teague, S. J.  (2019). Machine learning in mental health: a scoping review of methods and applications. Psychological Medicine, Advance online publication, 1-23. doi:10.1017/S0033291719000151

Taylor, N., Mayshak, R., Curtis, A., Coomber, K., Chikritzhs, T.N. and Miller, P.G. (2019). Investigating and validating methods of monitoring foot-traffic in night-time entertainment precincts in Australia. International Journal of Drug Policy, 66, pp. 23-29. DOI: 10.1016/j.drugpo.2019.01.009.
Link: http://dx.doi.org/10.1016/j.drugpo.2019.01.009

Voce, A., Calabria, B., Burns, R.,Castle, D., & McKetin, R. (2019). A systematic review of the symptom profile and course of methamphetamine-associated psychosis. Substance Use and Misuse, Advance online publication. doi:10.1080/10826084.2018.1521430

Williamson, A., Barker, D., Green, S., D'Este, C., Davies, H. T. O., Jorm, L., Shakeshaft, A., Rudge, S., Redman, S.  (2019). Increasing the capacity of policy agencies to use research findings: A stepped-wedge trial. Health Research Policy and Systems, 17(1). doi:10.1186/s12961-018-0408-8


Grigg, J. & Lenton, S. (2019). Shifting trends in the Perth ecstasy market: Harm reduction implications. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
Linkt: https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Drug%20Trends%20Bulletin_WA_Ecstasy%20market.pdf